SCHEMBL2422333

SCHEMBL2422333

O=C(O)CNC(=O)C=Cc1ccccc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 5/20 0.52
LMNA P02545 2/20 0.52
ITGB2 P05107 1/20 0.52
ICAM1 P05362 1/20 0.52
ITGAL P20701 1/20 0.52
MAPT P10636 3/20 0.48
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 1/20 0.48
MAOB P27338 2/20 0.48
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.47
HPGD P15428 1/20 0.46
NFE2L2 Q16236 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP1B1 Q16678 1/20 0.46
GAA P10253 1/20 0.45
RECQL P46063 1/20 0.44
EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2422331 1.00 POLB (0.54) POLBSMN1; SMN2LMNAITGB2ICAM1
SCHEMBL17219109 0.85 SMN1; SMN2 (0.50) POLBSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL15854197 0.85 SMN1; SMN2 (0.50) POLBSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL2420564 0.84 CYP1A2 (0.55) SMN1; SMN2LMNAMAPTALDH1A1KDM4E
SCHEMBL2420566 0.84 CYP1A2 (0.55) SMN1; SMN2LMNAMAPTALDH1A1KDM4E
SCHEMBL10102770 0.82 KMT2A (0.56) POLBSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL15854253 0.81 SMN1; SMN2 (0.52) POLBSMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL10102731 0.80 POLB (0.58) POLBSMN1; SMN2LMNAMAPTALDH1A1
Hydrochloric Acid SCHEMBL17219413 0.80 SMN1; SMN2 (0.51) POLBSMN1; SMN2LMNAMAPTALDH1A1
Hydrochloric Acid SCHEMBL17219417 0.80 SMN1; SMN2 (0.51) POLBSMN1; SMN2LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017772-B2 Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain GRUENENTHAL GMBH (DE) 2011-09-13 US disclosed
US-20100004252-A1 SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND/OR INHIBITION OF PAIN GRUENENTHAL GMBH (DE) 2010-01-07 US disclosed
US-7625900-B2 Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain GRUENENTHAL GMBH (DE) 2009-12-01 US disclosed
CN-101547925-A For KCNQ2/3K+Substituted tetrahydropyrrolopyrazine compounds with channel affinity and their use in medicine GRUENENTHAL GMBH (DE) 2009-09-30 CN disclosed
US-20080167315-A1 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain GRUENENTHAL GMBH (DE) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004252-A1 SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND/OR INHIBITION OF PAIN KCNQ2, KCNQ1, KCNJ2 POLB 4056/4885SMN1; SMN2 853/4885LMNA 2185/4885
US-20080167315-A1 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in the Treatment and/or Inhibition of Pain KCNQ2, KCNQ1, KCNJ2 POLB 4056/4885SMN1; SMN2 853/4885LMNA 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.